The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction

Biomaterials

Volumn 32, Issue 2, 2011, Pages 565-578

  Ruvinov, Emil ^a   Leor, Jonathan ^b   Cohen, Smadar ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Affinity binding; Alginate hydrogel; Hepatocyte growth factor; Insulin like growth factor 1; Myocardial regeneration

Indexed keywords

AFFINITY-BINDING; ALGINATE HYDROGEL; HEPATOCYTE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR-1; MYOCARDIAL REGENERATION;

BIOACTIVITY; BIOLOGICAL MATERIALS; BLOOD VESSELS; CELL DEATH; HYDROGELS; INSULIN; MASS SPECTROMETRY; PEPTIDES;

ALGINATE;

ALGINIC ACID; SCATTER FACTOR; SOMATOMEDIN C; TRANSCRIPTION FACTOR GATA 4;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL CYCLE; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; MASS SPECTROMETRY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

ALGINATES; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BIOCOMPATIBLE MATERIALS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GLUCURONIC ACID; HEPATOCYTE GROWTH FACTOR; HEXURONIC ACIDS; IMMUNOHISTOCHEMISTRY; INJECTIONS; INSULIN-LIKE GROWTH FACTOR I; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

RATTUS;

EID: 78449253232     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.08.097     Document Type: Article

References (43)

1. Ausoni S., Sartore S. From fish to amphibians to mammals: in search of novel strategies to optimize cardiac regeneration. J Cell Biol 2009, 184:357-364.
2. Forrester J.S., White A.J., Matsushita S., Chakravarty T., Makkar R.R. New paradigms of myocardial regeneration post-infarction: tissue preservation, cell environment, and pluripotent cell sources. JACC Cardiovasc Interv 2009, 2:1-8.
3. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
4. Hausenloy D.J., Yellon D.M. Cardioprotective growth factors. Cardiovasc Res 2009, 83:179-194.
5. Hwang H., Kloner R.A. Improving regenerating potential of the heart after myocardial infarction: factor-based approach. Life Sci 2010, 86:461-472.
6. Laflamme M.A., Zbinden S., Epstein S.E., Murry C.E. Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu Rev Pathol 2007, 2:307-339.
7. Ebelt H., Jungblut M., Zhang Y., Kubin T., Kostin S., Technau A., et al. Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells 2007, 25:236-244.
8. Tomita N., Morishita R., Taniyama Y., Koike H., Aoki M., Shimizu H., et al. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 2003, 107:1411-1417.
9. Suleiman M.S., Singh R.J., Stewart C.E. Apoptosis and the cardiac action of insulin-like growth factor I. Pharmacol Ther 2007, 114:278-294.
10. Wang Y., Ahmad N., Wani M.A., Ashraf M. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J Mol Cell Cardiol 2004, 37:1041-1052.
11. Li Q., Li B., Wang X., Leri A., Jana K.P., Liu Y., et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 1997, 100:1991-1999.
12. Freeman I., Kedem A., Cohen S. The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 2008, 29:3260-3268.
13. Freeman I., Cohen S. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 2009, 30:2122-2131.
14. Ruvinov E., Leor J., Cohen S. The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials 2010, 31:4573-4582.
15. Landa N., Miller L., Feinberg M.S., Holbova R., Shachar M., Freeman I., et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008, 117:1388-1396.
16. Leor J., Tuvia S., Guetta V., Manczur F., Castel D., Willenz U., et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol 2009, 54:1014-1023.
17. Dvir T., Levy O., Shachar M., Granot Y., Cohen S. Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly. Tissue Eng 2007, 13:2185-2193.
18. Ruvinov E., Sharabani-Yosef O., Nagler A., Einbinder T., Feinberg M.S., Holbova R., et al. Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium. Fibrogen Tissue Rep 2008, 1:7.
19. Harris W.A., Janecki D.J., Reilly J.P. Use of matrix clusters and trypsin autolysis fragments as mass calibrants in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2002, 16:1714-1722.
20. Etzion S., Battler A., Barbash I.M., Cagnano E., Zarin P., Granot Y., et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol 2001, 33:1321-1330.
21. Mehrhof F.B., Muller F.U., Bergmann M.W., Li P., Wang Y., Schmitz W., et al. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation 2001, 104:2088-2094.
22. Rodriguez M., Schaper J. Apoptosis: measurement and technical issues. J Mol Cell Cardiol 2005, 38:15-20.
23. Souders C.A., Bowers S.L., Baudino T.A. Cardiac fibroblast: the renaissance cell. Circ Res 2009, 105:1164-1176.
24. Lesman A., Gepstein L., Levenberg S. Vascularization shaping the heart. Ann N Y Acad Sci 2010, 1188:46-51.
25. Tsur-Gang O., Ruvinov E., Landa N., Holbova R., Feinberg M.S., Leor J., et al. The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials 2009, 30:189-195.
26. Liu Y., Guo J., Zhang P., Zhang S., Chen P., Ma K., et al. Bone marrow mononuclear cell transplantation into heart elevates the expression of angiogenic factors. Microvasc Res 2004, 68:156-160.
27. Ueda H., Nakamura T., Matsumoto K., Sawa Y., Matsuda H. A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats. Cardiovasc Res 2001, 51:41-50.
28. Loennechen J.P., Stoylen A., Beisvag V., Wisloff U., Ellingsen O. Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart. Am J Physiol Heart Circ Physiol 2001, 280:H2902-H2910.
29. Dobaczewski M., Gonzalez-Quesada C., Frangogiannis N.G. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol 2010, 48:504-511.
30. Frantz S., Bauersachs J., Ertl G. Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res 2009, 81:474-481.
31. Shan Z.X., Lin Q.X., Fu Y.H., Deng C.Y., Zhou Z.L., Zhu J.N., et al. Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun 2009, 381:597-601.
32. Nakamura T., Matsumoto K., Mizuno S., Sawa Y., Matsuda H. Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am J Physiol Heart Circ Physiol 2005, 288:H2131-H2139.
33. Pasumarthi K.B., Field L.J. Cardiomyocyte cell cycle regulation. Circ Res 2002, 90:1044-1054.
34. Reiss K., Cheng W., Pierzchalski P., Kodali S., Li B., Wang S., et al. Insulin-like growth factor-1 receptor and its ligand regulate the reentry of adult ventricular myocytes into the cell cycle. Exp Cell Res 1997, 235:198-209.
35. Kardami E. Stimulation and inhibition of cardiac myocyte proliferation in vitro. Mol Cell Biochem 1990, 92:129-135.
36. Jopling C., Sleep E., Raya M., Marti M., Raya A., Belmonte J.C. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 2010, 464:606-609.
37. Rysa J., Tenhunen O., Serpi R., Soini Y., Nemer M., Leskinen H., et al. GATA-4 is an angiogenic survival factor of the infarcted heart. Circ Heart Fail 2010, 3:440-450.
38. Pikkarainen S., Tokola H., Kerkela R., Ruskoaho H. GATA transcription factors in the developing and adult heart. Cardiovasc Res 2004, 63:196-207.
39. Urbanek K., Rota M., Cascapera S., Bearzi C., Nascimbene A., De Angelis A., et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 2005, 97:663-673.
40. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19:1029-1034.
41. Lu H., Xu X., Zhang M., Cao R., Brakenhielm E., Li C., et al. Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs. Proc Natl Acad Sci U S A 2007, 104:12140-12145.
42. Hao X., Silva E.A., Mansson-Broberg A., Grinnemo K.H., Siddiqui A.J., Dellgren G., et al. Angiogenic effects of sequential release of VEGF-A(165) and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 2007, 75:178-185.
43. Al-Shamkhani A., Duncan R. Radioiodination of alginate via covalently-bound tyrosinamide allows monitoring of its fate in vivo. J Bioactive Compatible Polym 1995, 10:4-13.